Literature DB >> 18209199

What can we learn from failed neuropathic pain trials?

Michael Polydefkis, Srinivasa N Raja.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18209199     DOI: 10.1212/01.wnl.0000298088.76718.18

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  2 in total

1.  Gabapentin extended-release tablets for the treatment of patients with postherpetic neuralgia: a randomized, double-blind, placebo-controlled, multicentre study.

Authors:  Mark S Wallace; Gordon Irving; Verne E Cowles
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

2.  Differential response to scrambler therapy by neuropathic pain phenotypes.

Authors:  Young Gi Min; Hyun Seok Baek; Kyoung-Min Lee; Yoon-Ho Hong
Journal:  Sci Rep       Date:  2021-05-12       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.